In the News
Recent Salk news from the Conquering Cancer team
Salk Institute mourns the loss of Professor Emeritus Walter Eckhart
LA JOLLA—Professor Emeritus Walter Eckhart, who served as director of the Salk Institute’s National Cancer Institute-designated Cancer Center and head of the Molecular and Cell Biology Laboratory for more than …
Salk Professor Janelle Ayres joins Cancer Grand Challenges team tackling cancer cachexia
LA JOLLA—An international team of researchers, including Salk Institute Professor Janelle Ayres, has been selected to receive a $25 million Cancer Grand Challenges award to tackle the challenge of cancer …
Salk Institute scientist Christina Towers named a 2022 Pew-Stewart Scholar for Cancer Research
LA JOLLA—Assistant Professor Christina Towers has been named a 2022 Pew-Stewart Scholar for Cancer Research as part of a partnership between The Pew Charitable Trusts and the Alexander and Margaret …
Cellular regeneration therapy restores damaged liver tissue faster than ever
Liver cells were partially reprogrammed into younger cells (red) using Yamanaka factors (white). The cell nuclei (blue) and cytoskeletal proteins (green) are also shown.Click here for a high-resolution image.Credit: Salk …
The protein that keeps the pancreas from digesting itself
LA JOLLA—Every day, your pancreas produces about one cup of digestive juices, a mixture of molecules that can break down the food you eat. But if these powerful molecules become …
Salk scientist Tony Hunter receives 2022 AACR Lifetime Achievement Award in Cancer Research
LA JOLLA—Salk Institute Professor Tony Hunter will receive the 2022 American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research at the April annual meeting of AACR, …
Salk scientists receive 2022 Mark Foundation Endeavor Award to study lung cancer
LA JOLLA—Professors Reuben Shaw, Susan Kaech, Christian Metallo and Alan Saghatelian have received a 2022 Mark Foundation for Cancer Research Endeavor Award to support their research exploring the metabolic changes …
The Lustgarten Foundation and Salk Institute announce strategic pancreatic cancer research partnership
LA JOLLA/NEW YORK—The Lustgarten Foundation and Salk Institute today announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new …
Salk scientists receive the 2021 ASPIRE award to study pancreatic cancer
LA JOLLA—Professor Ronald Evans and Assistant Professor Dannielle Engle have been granted a 2021 ASPIRE (Accelerating Scientific Platforms and Innovative Research) award to study the cellular and molecular drivers of …
Improving drug options for colorectal cancer patients
LA JOLLA—Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. …
Six Salk professors named among most highly cited researchers in the world
LA JOLLA—Salk Professors Joanne Chory, Joseph Ecker, Rusty Gage, Satchidananda Panda, Reuben Shaw and Kay Tye have been named to the Highly Cited Researchers list by Clarivate. The list identifies researchers who …
Uncovering how injury to the pancreas impacts cancer formation
Pancreatic acinar cells form a diverse population of new cell types in response to injury with the potential to limit or drive disease. Acinar-derived clones labeled in red and green.Click …Salk scientists reveal most commonly mutated gene in all cancers
LA JOLLA—For the past fifteen years, cancer researchers have been using DNA sequencing technology to identify the gene mutations that cause different forms of cancer. Now, Salk Assistant Professor Edward …
Peter Adams and Gerald Shadel awarded $13 million from NIH to study aging and liver cancer
LA JOLLA—Sanford Burnham Prebys Professor Peter D. Adams, who directs the Aging, Cancer and Immuno-oncology Program, and Salk Institute Professor Gerald Shadel, who directs the San Diego Nathan Shock Center …
The Salk Institute and Sanford Burnham Prebys license ULK1/2 inhibitors to Endeavor BioMedicines for treatment of cancer
LA JOLLA—The Salk Institute, along with Sanford Burnham Prebys, have signed an exclusive licensing agreement with California-based Endeavor BioMedicines for an intellectual property portfolio relating to cancer therapeutics and diagnostics …
Salk promotes Diana Hargreaves to associate professor
LA JOLLA—The Salk Institute has promoted Diana Hargreaves to the rank of associate professor for her notable contributions in epigenetic regulation, which make specific regions of our DNA accessible to …
“Bad fat” suppresses killer T cells from attacking cancer
LA JOLLA—In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech …
Salk scientists reveal role of genetic switch in pigmentation and melanoma
LA JOLLA—Despite only accounting for about 1 percent of skin cancers, melanoma causes the majority of skin cancer-related deaths. While treatments for this serious disease do exist, these drugs can …
